US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28

0.0000

Volume:- -

Turnover:- -

Market Cap:1.60M

PE:- -

High:53.28

Open:53.28

Low:53.28

Close:53.28

52wk High:56.90

52wk Low:44.36

Shares:30.00K

Float Shares:10.00K

Volume Ratio:2.68

T/O Rate:- -

Dividend:0.58

Dividend Rate:1.08%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Astrazeneca and Ionis Stocks Sink on Trial Miss and Analysts See an Overreaction

Ionis Pharmaceuticals Shares Sink After Late-stage Trial Failed to Meet Primary Goal

AstraZeneca (AZN) Gets a Buy from Jefferies

Astrazeneca Shares Slide After Wainua Treatment Fails Heart Disease Trial

Major Drugmaker Loses $27 Billion in Market Value After Failed Trial

Stocks to Watch: Levi Strauss, Pepsico, Astrazeneca

AstraZeneca says CARDIO-TTRansform trial did not meet primary efficacy endpoint

Clinical Trial for AstraZeneca's Cardiac Drug Fails to Meet Primary Goal, Shares Plunge 9%

Astrazeneca Non-oncology Trial Failure is Unexpected

AstraZeneca autosomal dominant polycystic kidney disease drug gets orphan status

AstraZeneca Halts Russian Real-World Selumetinib Study: What It Means for AZN Investors

Astrazeneca PLC Stock Falls Wednesday, Outperforms Market

Market Chatter: AstraZeneca, Daiichi Sankyo Near Deal With UK Regulator Over Enhertu Pricing

MT Newswires Live

Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...

AstraZeneca Acquires Rights for Potential Chinese Respiratory Disease Drug for up to $2.1 Billion

MT Newswires Live

PRESS Digest -wall Street Journal - July 8

SBP GROUP Shares Surge Over 4% in Early Trading Following Exclusive Licensing Deal with AstraZeneca for TQC3721

Race to Launch Weight-loss Pills Heats up as Smaller Players Advance

AstraZeneca (AZN) Gets a Buy from Citi

AstraZeneca Enters Multi-Year Genomics Agreement With Helix for Drug Discovery Research

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/AZNH/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1787342400000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"08-21 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":44.36,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650592490","title":"Astrazeneca and Ionis Stocks Sink on Trial Miss and Analysts See an Overreaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2650592490","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650592490?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:45","pubTimestamp":1783601100,"startTime":"0","endTime":"0","summary":"AstraZeneca shares slumped after the British-Swedish drugmaker announced a late-stage trial failure, denting the commercial prospects for its gene silencing drug. Analysts were seeing an overreaction.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU2236285917.USD","LU0708994859.HKD","LU1829250122.USD","LU2468319806.SGD","LU0058720904.USD","AZN","LU0889565916.HKD","LU0128525929.USD","BK4588","LU2237443549.SGD","LU0310800379.SGD","AZNH","LU0289739699.SGD","LU0109394709.USD","LU2237443465.HKD","IONS","LU1267930573.SGD","BK4568","LU0320765992.SGD","IE00B3T34201.USD","LU2089984988.USD","BK4007","LU2417539215.USD","LU2237443622.USD","BK4139","LU2237443978.SGD","LU0432979614.USD","LU2462157665.USD","BK4585","LU0029864427.USD","LU2456880835.USD","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650921640","title":"Ionis Pharmaceuticals Shares Sink After Late-stage Trial Failed to Meet Primary Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2650921640","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650921640?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:04","pubTimestamp":1783598640,"startTime":"0","endTime":"0","summary":"Shares of Ionis Pharmaceuticals tumbled after the company said a late-stage trial of its drug for a rare type of heart disease failed to meet its primary efficacy endpoint.The stock sank 23%, to $65.1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","LU0109394709.USD","BK4139","BK4007","LU2089984988.USD","LU2237443382.USD","IE00B3T34201.USD","LU0289739699.SGD","LU0889565916.HKD","LU2236285917.USD","LU2237443465.HKD","LU0029864427.USD","LU0708994859.HKD","BK4568","IONS","LU2462157665.USD","LU0432979614.USD","LU2237443978.SGD","LU0310800379.SGD","LU2237443622.USD","LU2237443895.HKD","LU2417539215.USD","LU2237443549.SGD","AZNH","LU0058720904.USD","LU0128525929.USD","LU2456880835.USD","LU0320765992.SGD","LU1829250122.USD","BK4585","AZN","LU2468319806.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650923925","title":"AstraZeneca (AZN) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2650923925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650923925?lang=en_us&edition=fundamental","pubTime":"2026-07-09 18:36","pubTimestamp":1783593369,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Leuchten maintained a Buy rating on AstraZeneca today and set a price target of £180.00. According to TipRanks, Leuchten ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-jefferies-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-jefferies-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU0708994859.HKD","LU1267930573.SGD","BK4585","LU0889565916.HKD","LU0029864427.USD","IE00B3T34201.USD","LU2236285917.USD","LU0432979614.USD","LU2417539215.USD","AZNH","BK4568","BK4007","LU2237443622.USD","LU0128525929.USD","LU2237443549.SGD","LU2462157665.USD","AZN","LU2237443465.HKD","LU2237443978.SGD","LU2237443895.HKD","LU2456880835.USD","BK4588","LU2237443382.USD","LU2468319806.SGD","LU2089984988.USD","LU0109394709.USD","LU0289739699.SGD","LU0058720904.USD","LU1829250122.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650925317","title":"Astrazeneca Shares Slide After Wainua Treatment Fails Heart Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2650925317","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650925317?lang=en_us&edition=fundamental","pubTime":"2026-07-09 18:32","pubTimestamp":1783593120,"startTime":"0","endTime":"0","summary":"AstraZeneca's stock tumbled after the pharmaceutical company said its Wainua drug failed to meet the primary target in a late-stage clinical trial for heart disease, denting investor hopes for pipelin","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","AZNH","LU0289739699.SGD","LU2462157665.USD","LU2468319806.SGD","LU0029864427.USD","LU0320765992.SGD","LU2456880835.USD","LU0109394709.USD","LU2417539215.USD","LU2237443549.SGD","LU0708994859.HKD","BK4585","LU2236285917.USD","BK4588","LU0058720904.USD","LU0432979614.USD","BK4568","LU2237443622.USD","IE00B3T34201.USD","LU2237443465.HKD","LU0128525929.USD","LU0310800379.SGD","LU2237443978.SGD","LU2089984988.USD","LU0889565916.HKD","LU1829250122.USD","LU2237443382.USD","LU2237443895.HKD","LU1267930573.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650928280","title":"Major Drugmaker Loses $27 Billion in Market Value After Failed Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2650928280","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650928280?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:53","pubTimestamp":1783590780,"startTime":"0","endTime":"0","summary":"Shares in AstraZeneca and Ionis decline on heart drug trial failureAstraZeneca's stock fell about 8% in London.Shares in AstraZeneca and Ionis Pharmaceuticals slid on Thursday after the companies anno","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","AZNH","LU0289739699.SGD","LU2462157665.USD","LU2468319806.SGD","LU0029864427.USD","LU0320765992.SGD","LU2456880835.USD","IONS","LU0109394709.USD","LU2417539215.USD","LU2237443549.SGD","LU0708994859.HKD","BK4585","LU2236285917.USD","BK4139","BK4588","LU0058720904.USD","LU0432979614.USD","BK4568","LU2237443622.USD","IE00B3T34201.USD","LU2237443465.HKD","LU0128525929.USD","LU0310800379.SGD","LU2237443978.SGD","LU2089984988.USD","LU0889565916.HKD","LU1829250122.USD","LU2237443382.USD","LU2237443895.HKD","LU1267930573.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650940191","title":"Stocks to Watch: Levi Strauss, Pepsico, Astrazeneca","url":"https://stock-news.laohu8.com/highlight/detail?id=2650940191","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650940191?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:22","pubTimestamp":1783588920,"startTime":"0","endTime":"0","summary":"AstraZeneca : Shares in the U.K. pharmaceutical company tumbled after it said a heart-disease treatment failed to meet its main target in a late-stage trial.Levi Strauss : Despite beating earnings expectations in its second-quarter report yesterday evening, the jeans maker failed to impress some on Wall Street, and shares fell in premarket trading.Porsche : Shares in the luxury carmaker slipped after it reported a big drop in first-half deliveries, especially in China and the U.S., where tax incentives for electric and hybrid cars expired.PepsiCo , Aritzia : The food-and-beverage company is due to report earnings this morning; Aritzia is also scheduled to post results later today.SK Hynix : The South Korean chip maker is expected today to set the price for its U.S. listing tomorrow, in what could be one of the world's largest stock sales.Volkswagen : Volkswagen's leadership will meet today to discuss an overhaul that could result in thousands of job cuts and factory closures.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","BK4094","LU2468319806.SGD","BK4504","LU2089984988.USD","LU2456880835.USD","IE000F7OJYX1.SGD","BK4007","LU0029864427.USD","BK4534","LU1894683264.USD","LU2236285917.USD","BK4581","BK4588","IE00BN8TJ469.HKD","LU2237443622.USD","LU0289739699.SGD","LU1244550577.SGD","IE00B3T34201.USD","LU2237443549.SGD","BK4585","BK4202","BK4177","LU0757428866.USD","FTXG","BK4568","IE00BBT3K403.USD","LU0058720904.USD","LU1244550221.USD","ATZAF","LU2237443382.USD","LU1929549753.HKD","AZNH","LU1829250122.USD","LU1894683348.USD","BK4566","BK4533","LU1244550494.USD","LU2237443465.HKD","LU0320765992.SGD","LU0098860793.USD","LU1815336091.USD","PEP","LEVI","IE000BZT7R73.USD","IE00BLSP4452.SGD","LU0432979614.USD","LU1162221912.USD","IE000SO60NU8.SGD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650194016","title":"AstraZeneca says CARDIO-TTRansform trial did not meet primary efficacy endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2650194016","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650194016?lang=en_us&edition=fundamental","pubTime":"2026-07-09 17:15","pubTimestamp":1783588532,"startTime":"0","endTime":"0","summary":"The CARDIO-TTRansform Phase III trial for AstraZeneca (AZN) and Ionis’ (IONS) Wainua in patients with transthyretin-mediated amyloid cardiomyopathy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-says-cardio-ttransform-trial-did-not-meet-primary-efficacy-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-says-cardio-ttransform-trial-did-not-meet-primary-efficacy-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443465.HKD","LU2237443549.SGD","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","AZN","IONS","LU0708994859.HKD","BK4007","LU2456880835.USD","AZNH","LU2237443978.SGD","LU0310800379.SGD","IE00B3T34201.USD","LU2417539215.USD","LU2462157665.USD","BK4568","LU1267930573.SGD","LU0058720904.USD","LU0128525929.USD","BK4585","BK4588","LU0432979614.USD","LU2237443622.USD","LU0889565916.HKD","LU0289739699.SGD","LU0029864427.USD","LU2237443382.USD","LU2237443895.HKD","BK4139","LU1829250122.USD","LU0109394709.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171557286","title":"Clinical Trial for AstraZeneca's Cardiac Drug Fails to Meet Primary Goal, Shares Plunge 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171557286","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171557286?lang=en_us&edition=fundamental","pubTime":"2026-07-09 16:41","pubTimestamp":1783586502,"startTime":"0","endTime":"0","summary":"Key clinical trial results for a new AstraZeneca heart drug have disappointed, sending the company's stock sharply lower.The British pharmaceutical giant announced that its investigational drug,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","BK4588","LU2236285917.USD","LU0708994859.HKD","LU1829250122.USD","BMED","IBBQ","LU0128525929.USD","LU1267930573.SGD","LU2417539215.USD","LU2237443978.SGD","LU0432979614.USD","LU0310800379.SGD","LU0058720904.USD","LU0889565916.HKD","LU0029864427.USD","LU0289739699.SGD","AZNH","LU2456880835.USD","LU2089984988.USD","BK4007","IE00B3T34201.USD","LU0109394709.USD","LU2237443622.USD","LU2468319806.SGD","LU2462157665.USD","LU2237443382.USD","LU0320765992.SGD","LU2237443465.HKD","LU2237443549.SGD","BK4585","LU2237443895.HKD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650294427","title":"Astrazeneca Non-oncology Trial Failure is Unexpected","url":"https://stock-news.laohu8.com/highlight/detail?id=2650294427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650294427?lang=en_us&edition=fundamental","pubTime":"2026-07-09 15:54","pubTimestamp":1783583640,"startTime":"0","endTime":"0","summary":"0754 GMT - AstraZeneca's negative headline results for its Wainua drug trial are unexpected, analysts at Bernstein say in a note. The U.K. drugmaker said the trial evaluating Wainua for transthyretin amyloid cardiomyopathy, a rare heart disease, didn't meet its primary objective. \"We've just spoken to AZN who are extremely and disappointed surprised by this news,\" the analysts say. \"We are too.\" The company recently doubled the trial size to 1,400 patients to increase the chances of positive, statistically rigorous results on the primary endpoint in the total population, Bernstein says. Shares fall 8.9%.  Dow Jones NewswiresJuly 09, 2026 03:54 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU1829250122.USD","LU1267930573.SGD","LU2089984988.USD","LU0289739699.SGD","AZNH","LU0708994859.HKD","BK4588","BK4007","LU2462157665.USD","BK4568","LU0128525929.USD","LU2468319806.SGD","LU0109394709.USD","AZN","LU2237443382.USD","LU2237443622.USD","LU2417539215.USD","BK4585","LU2237443978.SGD","LU0029864427.USD","LU2237443895.HKD","LU0432979614.USD","LU0889565916.HKD","LU2236285917.USD","LU0310800379.SGD","LU2237443465.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650915694","title":"AstraZeneca autosomal dominant polycystic kidney disease drug gets orphan status","url":"https://stock-news.laohu8.com/highlight/detail?id=2650915694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650915694?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:00","pubTimestamp":1783540820,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) Pharmaceuticals’ treatment of autosomal dominant polycystic kidney disease was granted FDA orphan designation, according to a pos...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-autosomal-dominant-polycystic-kidney-disease-drug-gets-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-autosomal-dominant-polycystic-kidney-disease-drug-gets-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","LU2237443549.SGD","LU2237443895.HKD","LU2468319806.SGD","LU0320765992.SGD","LU2236285917.USD","BK4007","AZNH","LU0432979614.USD","LABU","LU0029864427.USD","LU0708994859.HKD","LU1829250122.USD","LU2456880835.USD","LU0289739699.SGD","LU2417539215.USD","LU0109394709.USD","LU0889565916.HKD","LU0310800379.SGD","BK4585","LU2089984988.USD","LU2462157665.USD","LU2237443465.HKD","LU2237443622.USD","IE00B3T34201.USD","LU1267930573.SGD","LU2237443382.USD","AZN","BK4588","LU0058720904.USD","BK4568","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650997001","title":"AstraZeneca Halts Russian Real-World Selumetinib Study: What It Means for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2650997001","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650997001?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:30","pubTimestamp":1783528216,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The non-interventional study “Non-interventional Study of Patients With Pl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-halts-russian-real-world-selumetinib-study-what-it-means-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-halts-russian-real-world-selumetinib-study-what-it-means-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443465.HKD","LU2237443895.HKD","LU0320765992.SGD","IE00B3T34201.USD","LU0310800379.SGD","LU2237443549.SGD","LU2456880835.USD","BK4007","LU0889565916.HKD","BK4211","LU0128525929.USD","LU2468319806.SGD","BK4568","AZN","LU2237443622.USD","LU0432979614.USD","LU2237443382.USD","LU0029864427.USD","LU2236285917.USD","BK4588","BK4585","LU2237443978.SGD","LU1267930573.SGD","LU2089984988.USD","LU2462157665.USD","LU0708994859.HKD","LU0289739699.SGD","AZNH","LU0058720904.USD","LU2417539215.USD","LU1829250122.USD","LU0109394709.USD","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650399737","title":"Astrazeneca PLC Stock Falls Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2650399737","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650399737?lang=en_us&edition=fundamental","pubTime":"2026-07-09 00:00","pubTimestamp":1783526400,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC shed 0.9% to SEK1,848.00 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 1.8% to 2,670.47.The company closed SEK77.50 short of its 52-week high of SEK1,925.50, which the company achieved on April 10, 2026.Trading volume was 128,344, compared to the 50-day average trading volume of 285,852.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 08, 2026 12:00 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","IE00B3T34201.USD","LU2237443465.HKD","LU2237443895.HKD","LU0320765992.SGD","LU1829250122.USD","BK4585","LU2237443978.SGD","LU2236285917.USD","LU2417539215.USD","LU0708994859.HKD","LU2456880835.USD","AZNH","LU2237443382.USD","LU0310800379.SGD","LU0889565916.HKD","LU0109394709.USD","LU0432979614.USD","LU0058720904.USD","BK4007","BK4588","LU2237443549.SGD","LU2237443622.USD","AZN","BK4568","LU2089984988.USD","LU0289739699.SGD","LU1267930573.SGD","LU2462157665.USD","LU0029864427.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649953319","title":"Market Chatter: AstraZeneca, Daiichi Sankyo Near Deal With UK Regulator Over Enhertu Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2649953319","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649953319?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:08","pubTimestamp":1783512499,"startTime":"0","endTime":"0","summary":"Astrazeneca (AZN) and Daiichi Sankyo are in advanced talks with England's drug pricing regulator to make the breast cancer medicine Enhertu available to certain patients, Bloomberg reported Wednesday,","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2236285917.USD","LU2237443465.HKD","LU1829250122.USD","LU2237443895.HKD","LU1267930573.SGD","LU0109394709.USD","LU0889565916.HKD","BK4007","AZNH","LU0310800379.SGD","LU2417539215.USD","LU2237443978.SGD","BK4568","LU2237443382.USD","BK4585","LU2237443622.USD","LU0708994859.HKD","LU0432979614.USD","LU0289739699.SGD","LU0320765992.SGD","LU2468319806.SGD","LU2462157665.USD","LU0058720904.USD","BK4588","LU2456880835.USD","IE00B3T34201.USD","LU2237443549.SGD","LU0029864427.USD","AZN","LU2089984988.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649856998","title":"Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2649856998","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649856998?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:00","pubTimestamp":1783508400,"startTime":"0","endTime":"0","summary":"Apple to Spend $30 Billion on U.S.-Made Chips From BroadcomThe deal, for billions of chips, is the latest part of Apple's domestic investment pledge.----Trump-Backed Company Behind Family Crypto Wealt","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4553","LU0314109678.HKD","IE00B775SV38.USD","LU0056508442.USD","HK0000320264.USD","LU0077335932.USD","LU0985320562.USD","LU1829250122.USD","KURE","LU1815336760.USD","LU2211814178.USD","LU1242518931.SGD","LU0820561818.USD","LU1116320737.USD","LU2065170008.USD","LU0642271901.SGD","SGXZ99366536.SGD","IE00B3SWFQ91.USD","VGT","LU1226288253.USD","BK4585","LU0979878070.USD","LU0096362180.USD","LU2347655073.USD","LU2244417387.USD","BK4543","LU2361044865.SGD","IE00B19Z9P08.USD","LU1037948897.HKD","SGXZ51526630.SGD","LU2097344357.USD","GB00BDT5M118.USD","LU0127658192.USD","IE00B894F039.SGD","BK4571","LU1035775433.USD","IE0008368742.USD","IE00BYXW3230.USD","LU0965509101.SGD","LU1670710661.SGD","SG9999018857.SGD","LU1670628061.USD","LU0265550946.USD","LU0310800379.SGD","LU2592432038.USD","LU2236285917.USD","LU0345770993.USD","SG9999014559.SGD","LU0345768740.USD","LU0557290698.USD","LU1244550221.USD","LU0456855351.SGD","LU0058720904.USD","LU1861214812.USD","IE00BMPRXQ63.HKD","LU2355687059.USD","LU0053666078.USD","BK4596","IE00B19Z8W00.USD","IE00BLSP4452.SGD","LU0444973449.USD","LU0320765059.SGD","LU2168564495.EUR","LU0006061336.USD","BK4554","LU1242518857.USD","LU2133065610.SGD","LU1127390331.HKD","IE000KEQY171.SGD","LU1923623000.USD","LU2108987350.USD","LU0067412154.USD","LU0211328371.USD","IE00BZ1G4Q59.USD","LU1813983027.USD","LU2279689827.SGD","BK4533","AVL","IE00B031HY20.USD","LU2860962120.EUR","LU0942090050.USD","BK4568","LU2023251221.USD","LU0267386448.USD","LU0289961442.SGD","LU1145028129.USD","LU0661504455.SGD","IE00BJLML261.HKD","ROM","LU2242649171.HKD","IE000ITXATA3.USD","LU0957791311.USD","LU2756315664.SGD","LU0868494617.USD","LU2473716301.USD","LU2097829019.USD","LU0203201768.USD","LU0061474960.USD","LU2242650005.HKD","SG9999014567.USD","RTH","GSKH","AAPL","LU1202635105.USD","LU2931357623.SGD","LU2237443895.HKD","LU2125909247.SGD","LU0950375773.USD","SG9999002224.SGD","LU0096364046.USD","XLP","LU0889565833.HKD","LU2168564065.EUR","LU0648001328.SGD","LU2028103732.USD","LU0198837287.USD","LU1934455194.USD","BK4550","LU0980610538.SGD","SJM","LU0353189763.USD","LU2322448957.HKD","CHAT","LU0070217475.USD","LU0234572021.USD","LU2471134879.HKD","AVGG","LU2063271972.USD","LU1720051108.HKD","BK4512","BK4581","IE00B5MMRT66.SGD","LU1935042215.USD","LU0069063385.USD","LU1008478684.HKD","LU2458330169.SGD","LU2065169927.USD","LU2089283258.USD","LU1571399168.USD","LU1226287529.USD","HK0000165453.HKD","LU1400636574.HKD","IE00BN29S564.USD","IE00B543WZ88.USD","ARTY","TYLG","AVS","LU2458330243.SGD","IE00BYV24P56.USD","BK4592","LU0545039389.USD","BK4612","IE0004086264.USD","LU1119994496.HKD","IE000WAW04H5.SGD","LU2264538146.SGD","IE00BZ9MQY76.HKD","LU0957808578.USD","LU2552382132.HKD","LU0211327993.USD","LU0786609619.USD","LU1989772840.SGD","LU2462157665.USD","AAPW","LU0081259029.USD","LU0784385170.HKD","LU0011850046.USD","LU1914381329.SGD","SG9999018865.SGD","LU1935043536.SGD","LU2250418816.HKD","BK4573","LU2023250330.USD","LU0149725797.USD","LU1232071149.USD","LU1699723380.USD","LU2237443978.SGD","BK4551","LU0079474960.USD","LU1917777945.USD","LU0225283273.USD","IE00B19Z9505.USD","LU1803068979.SGD","LU0784385840.USD","LU2954938101.SGD","LU1035773651.USD","LU1935042488.USD","IE00B19Z8X17.USD","IE000Q6AESB8.SGD","SG9999014880.SGD","SG9999004303.SGD","LU2237443382.USD","BAI","LU0140636845.USD","LU1993786604.SGD","IE00BFSS7M15.SGD","IE0001KFT4U8.USD","AAPY","IE00B42XCP33.USD","LU0345769128.USD","LU0882574139.USD","LU1291159041.SGD","LU1861219969.SGD","SG9999014575.USD","IE00B7KXQ091.USD","LU2637965513.SGD","LU2360108059.USD","LU2168564149.EUR","LU2361045086.USD","IE00BWXC8680.SGD","LU1301847155.USD","LU1506573853.SGD","BK1191","LU0787776722.HKD","LU1718418525.SGD","LU1201861165.SGD","IE00BN8TJ469.HKD","LU1066053197.SGD","LU0154236417.USD","LU0234570918.USD","LU2764263203.CNY","LU2125154935.USD","BK4561","IE00BGHQDM52.EUR","LU2381873111.SGD","IE00BZ08YR35.GBP","LU2471134796.USD","AAPD","LU2462591350.SGD","SGXZ23171101.USD","LU1868837136.USD","LU2272731865.HKD","LU0672654240.SGD","AVGX","SG9999014542.SGD","IE00BSNM7G36.USD","IE00BJTD4V19.USD","LU0061475181.USD","LU1934455863.HKD","LU2750360641.GBP","IE0000B7K699.USD","LU1066051498.USD","LU0820561909.HKD","LU2271345857.HKD","LU2047632596.USD","IE0009G5SDU7.USD","LU0964807845.USD","SG9999004220.SGD","IE00B19Z9Z06.USD","LU0061474705.USD","LU0057025933.USD","LU0210528500.USD","LU1934455277.USD","LU1807302812.USD","LU1989771016.USD","BK4598","LU0476273544.USD","LU2360107325.USD","LU0124676726.USD","LU1988902786.USD","LU2720916845.USD","LU1974910355.USD","LU2896262040.SGD","AIFD","LU0943347566.SGD","LU2487616109.SGD","LU0738911758.USD","LU0320765646.SGD","LU2357305700.SGD","IE00BMPRXN33.USD","IE00BQXX3D17.EUR","SHOC","LU2360032135.SGD","XLK","LU2213496289.HKD","LU0175139822.USD","LU0130102774.USD","LU0784383803.USD","LU2505996509.AUD","AZN","LU0276348264.USD","BK1521","LU0823417737.USD","LU1582987324.SGD","SG9999001440.SGD","IE00BVYPNW00.USD","LU0128525929.USD","LU1069347547.HKD","IE0005OL40V9.USD","LU0082616367.USD","BK4212","GSK.UK","UGE","LU0912757837.SGD","IE00BK4W5L77.USD","SMHX","LU0795875086.SGD","GM","LU2420271590.USD","LU1791710400.SGD","LU0256863811.USD","LU1261432733.SGD","LU0130517989.USD","LU0109394709.USD","LU2023250504.SGD","LU0158827948.USD","LU0683600562.USD","LU1935042991.SGD","LU1935043023.USD","HK0000819398.USD","BK4559","LU0143551892.USD","IXN","LU2417539215.USD","USXF","LU0251132253.USD","IE0008369823.USD","LU0289960550.SGD","LU1585245621.USD","LU1551013342.USD","LU2552382058.USD","LU1960683339.HKD","LU0203347892.USD","LU0949170772.SGD","IE00BZ08YT58.USD","IE00BQXX3F31.USD","LU1815333072.USD","LU2039709279.SGD","LU1226287792.SGD","LU0823421416.USD","LU0080751232.USD","BK4574","LU0256863902.USD","SGXZ31699556.SGD","APLY","IE00BJTD4N35.SGD","IE0004445015.USD","LU0823434740.USD","NULC","LU2095319765.USD","IE00BBT3K403.USD","LU2463028550.USD","BK4155","IE0034235188.USD","GSK","ABFL","LU0528227936.USD","SG9999015952.SGD","SG9999014906.USD","LU1674673428.USD","LU2430703178.SGD","BK4170","LU0130103400.USD","SG9999015945.SGD","LU1629891620.HKD","IE000W1ABFV2.USD","LU1582986359.USD","AAPU","LU1989764748.USD","LU2265009873.SGD","LU2433249047.HKD","LU2111349929.HKD","MACW.SI","LU0689626769.HKD","LU1153585028.USD","LU0203345920.USD","LU1496350502.SGD","LU0203202063.USD","LU2210149790.SGD","LU2506952170.USD","LU1244550494.USD","IE0034235303.USD","LU0708994859.HKD","SG9999015358.SGD","LU2430703095.HKD","LU0070302665.USD","LU2237957811.SGD","LU2272731600.USD","BK4141","LU0109392836.USD","LU1839511570.USD","LU0215105999.USD","LU2065171402.SGD","LU2347655156.SGD","LU0314104364.USD","SOXQ","LU2506951875.HKD","LU2237443465.HKD","LU0048584097.USD","LU2023250843.SGD","IE00BMPRXR70.SGD","IE000MB6IJN5.SGD","IE00BKDWB100.SGD","BK4516","LU2041044095.USD","LU0130518102.USD","LU2087621335.USD","IE00B1XK9C88.USD","LU0170899867.USD","LU0965509283.SGD","LU1551013425.SGD","IE00B775H168.HKD","LU0689472784.USD","LU1712237335.SGD","IE0003U64NQ7.SGD","LU0501845795.SGD","LU1989764664.SGD","LU2999663052.SGD","LU1267930730.SGD","BK4113","LU2097344431.USD","LU0823421333.USD","LU0029864427.USD","LU0097036916.USD","LU1623119135.USD","LU2089985449.USD","LU1645745479.HKD","BK4532","IE00BJJMRX11.SGD","LU0726765562.USD","LU2210150020.SGD","CGDG","LU1116320901.HKD","IE00BFSS8Q28.SGD","LU0724617625.USD","LU1923622614.USD","BK4605","LU0109391861.USD","LU0174119429.USD","HK0000320223.HKD","IE000F7OJYX1.SGD","AZNH","LU2054465674.USD","LU0345770308.USD","SG9999001424.SGD","LU1674673691.USD","BK4534","HK0000914686.HKD","LU1804176565.USD","LU1852331112.SGD","LU1951198990.SGD","LU1868837300.USD","LU2275660780.HKD","LU2543165471.USD","LU0784384876.USD","SG9999015986.USD","IE000BZT7R73.USD","LU2361044949.HKD","IE00BKVL7J92.USD","IE000SO60NU8.SGD","LU1642822529.SGD","LU1720051017.SGD","TTEQ","AAPB","LU2272731782.SGD","IE00BK4W5M84.HKD","IE00BMCWC346.EUR","LU1430594728.SGD","BK4504","LU2083900584.USD","LU0133085943.USD","LU2092627202.USD","LU2125909593.SGD","LU2746668461.USD","LU1548497426.USD","BK4515","KR","LU0157215616.USD","LU0289739343.SGD","LU0308772762.SGD","LU1670711123.USD","BK1515","LU0274383776.USD","LU0444971666.USD","CIBR","LU0320765489.SGD","LU1206713676.USD","LU0965508806.USD","LU2505996681.GBP","HK0000914660.USD","SG9999003800.SGD","AVGU","BK4096","LU1989763427.SGD","IE00BVYPNV92.GBP","LU1868836757.USD","LU2298321311.HKD","SG9999011175.SGD","IE0009356076.USD","HK0000306685.HKD","TEK","IE00BDRTCR15.USD","ACI","BK4099","LU1316542783.SGD","LU2077746001.SGD","SOXX","BK4576","LU1400636657.SGD","SG9999017495.SGD","LU0302445910.USD","IE00B4YYXB79.USD","IE00BDGV0183.EUR","LU1066051811.HKD","LU0708995401.HKD","LU2092937148.SGD","LU0208291251.USD","LU2211815571.USD","LU2468319806.SGD","LU2471134952.CNY","FSTA","AVGO","LU0553294199.USD","BK4588","LU1069344957.HKD","LU0823434583.USD","IE00BDCRKT87.USD","SG9999015978.USD","LU0354030511.USD","LU0314106906.USD","IE00B4JS1V06.HKD","BK4527","LU0326950275.SGD","IE000M9KFDE8.USD","LU1732799900.SGD","LU2471134523.USD","LU1003077747.HKD","SG9999014898.SGD","LU2168564222.USD","LU0323591593.USD","LU1226288170.HKD","LU1732800096.USD","JGRO","LU0348723411.USD","LU1267930573.SGD","BK4555","IE00BVYPNQ40.USD","LU1046421795.USD","LU1989763690.USD","LU2750360997.AUD","LU0353189680.USD","LU1778281490.HKD","LU2430703251.USD","BK4505","LU1084165304.USD","BK4597","LU2125154778.USD","LU0880133367.SGD","LU2602419157.SGD","LU2461242641.AUD","LU1868836591.USD","LU2552382215.SGD","IE00BLSP4239.USD","LU0289739699.SGD","LU2106854487.HKD","LU1162221912.USD","LU1152091168.USD","LU2089984988.USD","IE00B3S45H60.SGD","LU0648000940.SGD","LU0417517546.SGD","LU1582986433.USD","LU2237443549.SGD","FAI","BK4566","LU0320765992.SGD","LU0795875169.SGD","LU0640476718.USD","LU3102509885.SGD","LU1235294995.USD","LU0719512351.SGD","LU1323610961.USD","USD","LU0861579265.USD","LU2247934214.USD","LU0494093205.USD","LU1670756490.USD","LU0210533765.USD","LU0466842654.USD","LU2322448791.USD","LU1670711040.USD","LU1066051225.USD","LU2092937221.SGD","LU0158827781.USD","LU0820562030.AUD","LU0889565916.HKD","LU1280957306.USD","LU2452424414.USD","SG9999014914.USD","LU0823417653.USD","LU0266013472.USD","IE00BVYPNP33.GBP","LU0868494708.USD","SG9999000418.SGD","LU1152091754.HKD","BK4007","IE0004091025.USD","LU0345769631.USD","IE00B3PB1722.GBP","LU0511384066.AUD","LU1064131342.USD","IE000YTNTUN2.SGD","LU1868836914.USD","LU1992135472.HKD","LU0072461881.USD","LU2756315318.SGD","METV","LU2237438978.USD","LU1328277881.USD","WMT","BK4575","LU1951186391.HKD","LU2100268510.USD","LU0949170426.SGD","VT","LU1037948541.HKD","LU2462591277.SGD","IE00B3T34201.USD","LU1226287875.USD","01093","LU0238689110.USD","BK4507","LU0477156797.USD","LU2456880835.USD","LU1670710588.SGD","LU0788109477.HKD","LU0072913022.USD","LU2764263039.SGD","IE00B5949003.HKD","SG9999002232.USD","LU1670627923.USD","LU2746668974.SGD","LU1366333091.USD","LU2360106780.USD","LU0477156953.USD","LU0006306889.USD","LU2764262908.HKD","BK4501","IE00BQXX3C00.GBP","SG9999015341.SGD","WMTI","CGGO","LU0315179316.USD","LU1201861249.SGD","LU2286300806.USD","LU1823568750.SGD","BK4579","LU1496350171.SGD","LU0432979614.USD","SPTE","FTEC","LU1992135399.USD","LU0345768153.USD","LU2168563687.JPY","LU0162691827.USD","LU2087625088.SGD","IE00B1BXHZ80.USD","LU0965509010.AUD","LU1366192091.USD","LU2237443622.USD","LU1691799644.USD","LU0354030438.USD","IETC","LU0316494557.USD","IE0034235295.USD","LU1244550577.SGD","LU1803068623.USD","HK0000532082.HKD","LU2065171311.SGD","IE00BJJMRY28.SGD","LU1951200564.SGD","TRFK","IE00BKPKM429.USD","LU0310799852.SGD","LU1267930490.SGD","AVGW","LU1400636491.USD","LU1582987597.SGD","LU1989772923.USD","LU2237957902.USD","LU2506951958.HKD","AAPX","LU2191332357.HKD","LU0472753341.HKD","LU0211331839.USD","LU2506952097.USD","LU0072462426.USD","DJTWW","SGXZ81514606.USD","LU0187121727.USD","LU2403377893.USD","IE00BZ08YS42.EUR","IE0004445239.USD","LU0094547139.USD","LU1206712785.SGD","TDIV","LU2089284900.SGD","HK0000306701.USD","LU0106261372.USD","LU1814569148.SGD","LU0312595415.SGD","LU0210536198.USD","LU1791710582.SGD","IE00BGHQF631.EUR","LU0265550359.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649967596","title":"AstraZeneca Acquires Rights for Potential Chinese Respiratory Disease Drug for up to $2.1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2649967596","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649967596?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:08","pubTimestamp":1783505312,"startTime":"0","endTime":"0","summary":"AstraZeneca  has signed a deal worth up to $2.1 billion with Sino Biopharmaceutical's unit, Chia Tai Tianqing Pharmaceutical, for the development, manufacturing and commercialization of the Chia Tai Tianqing's chronic respiratory disease drug candidate TQC3721, Sino Biopharmaceutical said Wednesday.The deal stipulates that Chia Tai Tianqing will receive an upfront payment of $200 million to grant AstraZeneca an exclusive license to develop, manufacture and commercialize TQC3721 outside China, Sino said.The deal includes additional development, regulatory and sales milestones totaling up to $1.9 billion, as well as tiered royalties ranging up to double-digit percentages based on annual net sales, Sino said.A nebulized formulation of the drug currently being evaluated in a late-stage clinical trial in China, while a dry powder inhaler formulation is undergoing a mid-stage trial, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B3T34201.USD","LU2237443622.USD","LU0128525929.USD","LU0708994859.HKD","LU0058720904.USD","LU2462157665.USD","LU2237443978.SGD","LU0889565916.HKD","LU1267930573.SGD","LU2417539215.USD","LU0289739699.SGD","LU2237443465.HKD","LU2237443549.SGD","LU2237443382.USD","AZNH","BK4007","LU2236285917.USD","LU1829250122.USD","LU0109394709.USD","AZN","BK4585","LU0029864427.USD","LU0320765992.SGD","BK4568","LU2089984988.USD","LU0432979614.USD","LU0310800379.SGD","LU2456880835.USD","LU2237443895.HKD","LU2468319806.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649459968","title":"PRESS Digest -wall Street Journal - July 8","url":"https://stock-news.laohu8.com/highlight/detail?id=2649459968","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649459968?lang=en_us&edition=fundamental","pubTime":"2026-07-08 14:18","pubTimestamp":1783491500,"startTime":"0","endTime":"0","summary":"PRESS DIGEST -Wall Street Journal - July 8July 8 (Reuters)-The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.- ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nL6N43A0B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703178.SGD","LU2125154935.USD","LU0971552830.HKD","LU0061474960.USD","LU0353189680.USD","LU1674673691.USD","LU2237443978.SGD","WMTI","LU0345770308.USD","LU1674673428.USD","LU0238689110.USD","LU0314104364.USD","LU2417539215.USD","LU2505996509.AUD","LU1066053197.SGD","LU1066051498.USD","LU1201861249.SGD","BK1181","RTH","LU1487256676.USD","AZNH","LU1066051225.USD","LU1228905037.USD","LU2646069778.SGD","SBHMY","LU0557290698.USD","BK4596","LU0738911758.USD","WMT","LU2430703251.USD","BK4504","XLP","LU0175139822.USD","LU2592432038.USD","IE0034235188.USD","LU0312595415.SGD","BK1521","LU0265550359.USD","IE00BWDBJ516.SGD","LU1066051811.HKD","LU1035773651.USD","SGXZ57979304.SGD","LU1988902786.USD","BK4534","LU2125154778.USD","LU0310799852.SGD","LU2746668461.USD","LU2089984988.USD","GB00BDT5M118.USD","LU0306807586.USD","LU0029864427.USD","LU0128525929.USD","LU0161305163.EUR","BK4532","BK4559","LU1309081286.SGD","LU2468319806.SGD","LU2361045086.USD","LU1064131342.USD","IE00B3T34201.USD","LU0256863811.USD","LU2087625088.SGD","LU2361044865.SGD","LU0130102774.USD","LU0320765992.SGD","LU2471134523.USD","UGE","BK4585","LU1645745479.HKD","BK4550","HK0000819398.USD","LU1585245621.USD","LU0971552673.USD","LU0289960550.SGD","LU1400636657.SGD","LU0321505868.SGD","LU0310800379.SGD","LU0575583348.USD","LU0889565916.HKD","BK4581","LU2746668974.SGD","LU2361044949.HKD","LU2750360641.GBP","BK1191","LU0640476718.USD","01177","LU2265009873.SGD","LU0417517546.SGD","06880","LU1267930490.SGD","BK4533","LU2275660780.HKD","LU2462157665.USD","LU0980610538.SGD","IE00BQJZX424.USD","LU0130517989.USD","LU1202635105.USD","ACI","LU2237443465.HKD","LU2237443895.HKD","LU0203347892.USD","LU0225771236.USD","LU1829250122.USD","LU0545039389.USD","LU1989763690.USD","BK5011","IE00BZ08YT58.USD","LU2381873111.SGD","LU2236285917.USD","LU1302929846.USD","LU0477156953.USD","LU0225284248.USD","LU1804176565.USD","LU1003077747.HKD","SG9999013999.USD","BK4597","LU2456880835.USD","LU1098665638.USD","LU2237443382.USD","HK0000165453.HKD","LU0648001328.SGD","LU2750360997.AUD","LU1778281490.HKD","LU2264538146.SGD","LU0109394709.USD","LU0432979614.USD","BK4007","LU2097829019.USD","BK4588","LU0345770993.USD","BK4155","LU2237443622.USD","LU2461242641.AUD","LU0306806265.USD","LU1064927863.SGD","BK4113","LU0545562505.USD","BK1589","LU1035777561.USD","LU1481599808.USD","LU0203345920.USD","LU2471134796.USD","LU1366192091.USD","LU1814569148.SGD","IE0034235071.USD","IE0001KFT4U8.USD","LU0985481810.HKD","KR","LU0289739699.SGD","FSTA","LU1267930573.SGD","LU2471134879.HKD","LU2505996681.GBP","LU1400636491.USD","LU2360032135.SGD","LU1481600234.SGD","LU0661504455.SGD","SG9999001176.USD","LU0553294199.USD","LU1228905540.USD","LU2430703095.HKD","LU0708994859.HKD","LU0096362180.USD","LU1116320901.HKD","LU1280957306.USD","LU0321505439.SGD","IE00BZ08YR35.GBP","LU1015430645.USD","LU1983299246.USD","LU0149725797.USD","LU0058720904.USD","LU1815333072.USD","SG9999001176.SGD","LU0109981661.USD","LU2237443549.SGD","LU0225283273.USD","LU0353189763.USD","IE000M9KFDE8.USD","LU0302445910.USD","AZN","GSK.UK","LU0211331839.USD","LU0957791311.USD","BK4568","LU0211327993.USD","LU1430594728.SGD","LU1670756490.USD","LU0265550946.USD","LU1046248800.SGD","LU0949170772.SGD","LU2471134952.CNY","BK1515","LU0211328371.USD","LU1069347547.HKD","LU1400636574.HKD","IE00BZ08YS42.EUR","LU0256863902.USD","LU1989763427.SGD","LU1116320737.USD","LU0987226296.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164500073","title":"SBP GROUP Shares Surge Over 4% in Early Trading Following Exclusive Licensing Deal with AstraZeneca for TQC3721","url":"https://stock-news.laohu8.com/highlight/detail?id=1164500073","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164500073?lang=en_us&edition=fundamental","pubTime":"2026-07-08 09:36","pubTimestamp":1783474611,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) rose more than 4% during the morning session. At the time of writing, the stock was up 3.94% to HK$5.01, with a turnover of HK$828.617 million. Key Development On July 8,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","VXUS","LU2237443895.HKD","IE00B3T34201.USD","LU2237443549.SGD","BK4568","LU2237443382.USD","LU1267930573.SGD","LU2236285917.USD","HK0000165453.HKD","LU2237443978.SGD","IE00BZ08YT58.USD","LU2468319806.SGD","AZNH","BK1515","LU2417539215.USD","LU0320765992.SGD","LU2089984988.USD","LU0058720904.USD","BK4007","BK1191","BK1589","IE00BZ08YR35.GBP","LU0109394709.USD","LU2456880835.USD","LU0708994859.HKD","LU0029864427.USD","AZN","LU2462157665.USD","01177","LU0128525929.USD","IE00BZ08YS42.EUR","LU0289739699.SGD","LU0889565916.HKD","LU0432979614.USD","LU0310800379.SGD","BK4585","BK4588","LU2237443622.USD","BK1521","LU1829250122.USD","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649402939","title":"Race to Launch Weight-loss Pills Heats up as Smaller Players Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2649402939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649402939?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:12","pubTimestamp":1783440755,"startTime":"0","endTime":"0","summary":"FACTBOX-Race to launch weight-loss pills heats up as smaller players advanceAdds details of Kailera Therapeutics' obesity drug in paragraphs 1,2 and 25July 7 (Reuters)-Kailera Therapeutics'KLRA.Ooral ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4391DU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014898.SGD","IE00BWXC8680.SGD","AGNG","LU1066051811.HKD","LU2023251221.USD","LU1069344957.HKD","LU2491050071.SGD","LU0708995401.HKD","LU0133085943.USD","LU0708994859.HKD","LU1989772923.USD","LU0882574055.USD","IE00B19Z3581.USD","LU2106854487.HKD","RXL","LU0158827781.USD","LU0114720955.EUR","LU0321505439.SGD","LU0130102774.USD","IE00BLSP4239.USD","LU2125154935.USD","LU1883839398.USD","LLY","LU2237443382.USD","LU0130517989.USD","LU2552382215.SGD","NVOX","LU2023250504.SGD","LU0471298694.HKD","LU1127390331.HKD","IE00BZ1G4Q59.USD","LU1035773651.USD","SG9999015978.USD","LU2433249047.HKD","LU0225283273.USD","LU2750360641.GBP","IXJ","LU0211331839.USD","SG9999002224.SGD","LU1868837136.USD","IYH","LU2756315318.SGD","LU2168564495.EUR","LU0683600562.USD","LU1868836757.USD","LU0289739699.SGD","LU2264538146.SGD","LU2237443978.SGD","LU0353189680.USD","LU1551013425.SGD","LU1941712348.USD","BK4588","LU1934455863.HKD","LU1868837300.USD","LLYX","SG9999014906.USD","LU0477156953.USD","LU2023250843.SGD","IE00B7KXQ091.USD","LU1066051498.USD","MEDX","LU2097828714.EUR","LU1037948897.HKD","LU1804176565.USD","LU2087625088.SGD","LU2357627491.SGD","KLRA","SG9999014542.SGD","FHLC","LU2168564222.USD","SG9999014914.USD","LU2417539215.USD","IE00B19Z3B42.SGD","LU1116320737.USD","LU0094547139.USD","LU2089283258.USD","LU0820561909.HKD","LU0306806265.USD","LU2324357040.USD","LU2125909247.SGD","LU2756315664.SGD","LU0640476718.USD","LU0965509101.SGD","LU1712237335.SGD","NVO","LU0208291251.USD","IE000M9KFDE8.USD","LU0310800379.SGD","LU0455707207.USD","IE00BKDWB100.SGD","LU0203345920.USD","LU1116320901.HKD","SG9999001440.SGD","XLV","IE00BLSP4452.SGD","JDOC","LU0859254822.USD","LU0320765992.SGD","IE00BJJMRX11.SGD","LU0320765489.SGD","LU2089984988.USD","LU0823416689.USD","WDNA","LU0345770308.USD","LU1551013342.USD","IE00BK4W5M84.HKD","LU2360032135.SGD","IE00BSNM7G36.USD","LU0471298777.SGD","LU1868836914.USD","LU2108987350.USD","LU1623119135.USD","SG9999018857.SGD","01801","LU2602419157.SGD","NVOH","LU0109394709.USD","LU0203202063.USD","LU0316494557.USD","LU1066051225.USD","LU2360106947.USD","LU0097036916.USD","LU1267930573.SGD","LU0170899867.USD","LU0203347892.USD","LU0203201768.USD","LU1814569148.SGD","LU0061475181.USD","ELIL","LU2097828474.EUR","LU2462157665.USD","IE00B1BXHZ80.USD","LU0648001328.SGD","LU0122379950.USD","LU0823434583.USD","LU2089284900.SGD","SG9999001176.SGD","LU2063271972.USD","LU0964807845.USD","LU1923622614.USD","LU2097828557.USD","LU1868836591.USD","LU0128525929.USD","LU2237443622.USD","LU2361044865.SGD","LU0868494708.USD","VKTX","LU2236285917.USD","LU2552382058.USD","PAWZ","SG9999015945.SGD","BK4592","LU0198837287.USD","SGXZ57979304.SGD","LU1699723380.USD","BK1589","LU1093756325.SGD","LU2237443549.SGD","LU2213496289.HKD","LU0006306889.USD","LU0502904849.HKD","LU0320765059.SGD","LU2468319806.SGD","BK4533","LU0861579265.USD","SGXZ99366536.SGD","GB00BDT5M118.USD","VHT","LU2211815571.USD","SG9999001176.USD","LU1291159041.SGD","LU2237438978.USD","LU1894683348.USD","LU0320765646.SGD","LU0238689110.USD","LU0432979614.USD","LU0985481810.HKD","AZNH","PFE","LU0256863902.USD","BK4007","LU1069347547.HKD","01672","IE00BJJMRY28.SGD","LU0058720904.USD","LU0889565916.HKD","LU1064131342.USD","LU2125909593.SGD","LU2237443895.HKD","LU2456880835.USD","SG9999015986.USD","LU2111349929.HKD","SG9999015952.SGD","LU1629891620.HKD","IE00B3T34201.USD","LU2237443465.HKD","BK4568","LU1974910355.USD","LU1037948541.HKD","IE0004445015.USD","LU2471134879.HKD","LLYZ","LU0943347566.SGD","PPH","LU0070302665.USD","LU0321505868.SGD","LU1093756168.USD","LU2471134952.CNY","LU1323610961.USD","LU0345770993.USD","KURE","LU0354030438.USD","IE00BKPKM429.USD","ILDR","LU1061106388.HKD","CANC","BK4581","IE00BFTCPJ56.SGD","LU0210536198.USD","LU2168564149.EUR","LU0266013472.USD","LU2271345857.HKD","LU1989771016.USD","LU2097828805.USD","LU2168563687.JPY","SG9999014575.USD","CURE","BMED","LU2328871848.SGD","LU2265009873.SGD","LU2552382132.HKD","BK4559","LU2471134523.USD","HRTS","PJP","BK4599","GPCR","LU0672654240.SGD","LU2491049909.HKD","SG9999017495.SGD","LU0306807586.USD","LU0417517546.SGD","BK4532","LU0096364046.USD","LU1366192091.USD","IE00BBT3K403.USD","LU0965508806.USD","SGXZ81514606.USD","LU2746668974.SGD","BK4585","LU1571399168.USD","LU0820561818.USD","LU2488822045.USD","LU2461242641.AUD","LU1720051108.HKD","BK4516","LU0079474960.USD","LU1430594728.SGD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU1548497426.USD","IE00BJLML261.HKD","LU1829250122.USD","LU1280957306.USD","SG9999011175.SGD","LU1941712264.USD","AZN","LU2125154778.USD","IE0002141913.USD","IE0005OL40V9.USD","BK1161","LU0234572021.USD","LU0868494617.USD","MEDI","LU0106261372.USD","LU0787776722.HKD","LU1585245621.USD","BK1515","SGXZ51526630.SGD","LU0265550946.USD","LU0385154629.USD","IE00BKVL7J92.USD","LU2028103732.USD","OZEM","LU2491050154.USD","LU0323591593.USD","LU2361045086.USD","LU1989772840.SGD","LU1917777945.USD","LU1934455277.USD","IE00B1XK9C88.USD","LU1267930730.SGD","LU0109391861.USD","SG9999014567.USD","SG9999014880.SGD","LU0942090050.USD","LU0353189763.USD","LU1983299246.USD","LU0823434740.USD","LU1894683264.USD","LU0965509283.SGD","LU1969619763.USD","LU0158827948.USD","BK4534","LU0029864427.USD","LU0689472784.USD","LU1145028129.USD","LU1988902786.USD","LU2746668461.USD","LU0820562030.AUD","LU2357305700.SGD","LLII","LU0882574139.USD","LU2097828631.EUR","ELIS","LU0265550359.USD","LU0985320562.USD","LU0154236417.USD","SGXZ31699556.SGD","THNR","LU1023059063.AUD","LU0466842654.USD","SG9999002232.USD","IE00B4R5TH58.HKD","SG9999015341.SGD","LU0225771236.USD","LU1232071149.USD","LU2750360997.AUD","LU1201861249.SGD","LU2112291526.USD","IE00BN29S564.USD","IE0004445239.USD","LU2168564065.EUR","IE00BK4W5L77.USD","SG9999015358.SGD","LU2242644610.SGD","LU2896262040.SGD","IE00BJT1NW94.SGD","LU0354030511.USD","LU2471134796.USD","LU1162221912.USD","IE0002270589.USD","IE00BFSS8Q28.SGD","HK0000165453.HKD","MRK","IHE","BK4139","SG9999018865.SGD","IE00B4JS1V06.HKD","IE00B775H168.HKD","LU1057294990.SGD","BK4550","LU2361044949.HKD","LU0980610538.SGD","LU0256863811.USD","LU1929549753.HKD","IE00BFSS7M15.SGD","LU1035775433.USD","LU2596442595.SGD","LU0456855351.SGD","BK1583","IE00B2B36J28.USD","IE0001KFT4U8.USD","IE0009355771.USD","LU1934455194.USD","SG9999013999.USD","LU0965509010.AUD","LU0098860793.USD","LU2023250330.USD","FTXH","LU0225284248.USD","LU1720051017.SGD","SG9999003800.SGD","LU0786609619.USD","IE00BN8TJ469.HKD","GDOC","SG9999014559.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649399119","title":"AstraZeneca (AZN) Gets a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2649399119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649399119?lang=en_us&edition=fundamental","pubTime":"2026-07-07 23:55","pubTimestamp":1783439723,"startTime":"0","endTime":"0","summary":"Citi analyst Graham Parry maintained a Buy rating on AstraZeneca yesterday. The company’s shares closed today at p14,100.00. According to TipRanks,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-citi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-citi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","AZN","LU2462157665.USD","LU0310800379.SGD","LU0432979614.USD","BK4585","LU2237443622.USD","LU2089984988.USD","BK4568","LU2456880835.USD","BK4007","LU2237443978.SGD","LU2237443895.HKD","LU0289739699.SGD","LU2417539215.USD","LU2237443549.SGD","IE00B3T34201.USD","LU0320765992.SGD","LU0708994859.HKD","LU0128525929.USD","LU2468319806.SGD","AZNH","LU2237443382.USD","LU1829250122.USD","LU2236285917.USD","BK4588","LU0029864427.USD","LU1267930573.SGD","LU0058720904.USD","LU2237443465.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649603933","title":"AstraZeneca Enters Multi-Year Genomics Agreement With Helix for Drug Discovery Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2649603933","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649603933?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:51","pubTimestamp":1783432313,"startTime":"0","endTime":"0","summary":"AstraZeneca  has entered a multi-year agreement to access Helix's genomic datasets to support research for drug discovery and development, Helix said Tuesday.Under the agreement, AstraZeneca will gain access to Helix's GenoSphere cohorts, which combine Exome+ genomic sequencing and longitudinal clinical data across multiple disease areas, including cardiometabolic, respiratory and autoimmune disorders, among others, the company said.Financial terms of the deal were not disclosed.Shares of AstraZeneca were 1.3% higher in early Tuesday trading.Price: 192.64, Change: +2.51, Percent Change: +1.32","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0058720904.USD","LU1829250122.USD","LU2237443978.SGD","LU0128525929.USD","LU0109394709.USD","LU2237443549.SGD","LU0889565916.HKD","LU2236285917.USD","IE00B3T34201.USD","LU2237443622.USD","LU0432979614.USD","LU0708994859.HKD","LU0029864427.USD","BK4007","AZNH","LU0289739699.SGD","LU0320765992.SGD","AZN","LU2237443465.HKD","LU2468319806.SGD","LU2417539215.USD","BK4585","LU2456880835.USD","LU2089984988.USD","LU0310800379.SGD","LU1267930573.SGD","BK4568","LU2237443382.USD","LU2237443895.HKD","BK4588","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}